Cross Country GC receives 33,644-share stock grant

Cross Country Healthcare General Counsel Susan E. Ball reported routine equity compensation and related tax withholding transactions.

Rhea-AI Filing Summary

Cross Country Healthcare General Counsel Susan E. Ball reported routine equity compensation and related tax withholding transactions. On March 31, 2026, she received a grant of 33,644 shares of common stock at no cost, described as restricted shares that will vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.

On the same date, 1,689 and 2,014 shares were withheld at $9.40 per share to satisfy tax withholding obligations for restricted stock that vested on March 31, 2026. After these transactions, she directly holds 241,777 shares of Cross Country Healthcare common stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Ball Susan E

Role General Counsel and Secretary

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	33,644	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,689	$9.40	$16K
Exercise Price or Tax Liability	Common Stock	2,014	$9.40	$19K

Holdings After Transaction: Common Stock — 241,777 shares (Direct)

Footnotes (2)

1. F1. These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.
2. F2. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

Key Figures

Restricted stock grant: 33,644 shares Shares withheld for taxes (lot 1): 1,689 shares at $9.40 Shares withheld for taxes (lot 2): 2,014 shares at $9.40 +2 more

5 metrics

Restricted stock grant 33,644 shares Awarded on March 31, 2026 to General Counsel as common stock

Shares withheld for taxes (lot 1) 1,689 shares at $9.40 Withheld to satisfy tax obligations for vested restricted stock

Shares withheld for taxes (lot 2) 2,014 shares at $9.40 Additional withholding for tax obligations on vested restricted stock

Total tax withholding shares 3,703 shares Aggregate shares withheld to satisfy tax obligations on March 31, 2026

Post-transaction holdings 241,777 shares Directly owned common stock after all reported transactions

Key Terms

restricted shares of common stock, vest in three substantially equal installments, tax withholding obligations, Grant, award, or other acquisition, +1 more

5 terms

restricted shares of common stock financial

"These restricted shares of common stock vest in three substantially equal installments."

Restricted shares of common stock are company shares that cannot be sold or transferred until specific conditions are met, such as a set time period, performance targets, or regulatory approvals; they are often granted to founders, employees or early investors. They matter to investors because when the restrictions lift those shares can enter the market and increase the supply, potentially diluting existing holders and changing the stock’s price, similar to a locked faucet being opened and more water joining the flow.

vest in three substantially equal installments financial

"The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029."

tax withholding obligations financial

"These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description: Payment of exercise price or tax liability by delivering securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CCRN executive Susan E. Ball report?

Susan E. Ball reported a grant of 33,644 restricted common shares and two tax-withholding dispositions totaling 3,703 shares. The withheld shares covered tax obligations on restricted stock that vested on March 31, 2026, and were not open-market sales.

How many Cross Country Healthcare (CCRN) shares does Susan E. Ball hold after these Form 4 transactions?

After these transactions, Susan E. Ball directly holds 241,777 shares of Cross Country Healthcare common stock. This figure reflects the new restricted stock grant and the shares withheld to cover tax obligations on previously vesting restricted stock.

How do the newly granted CCRN restricted shares vest for Susan E. Ball?

The 33,644 restricted shares granted to Susan E. Ball vest in three substantially equal installments. According to the disclosure, the installments will vest on March 31, 2027, March 31, 2028, and March 31, 2029, subject to the applicable award terms.

Were the CCRN shares disposed by Susan E. Ball part of an open-market sale?

No. The 1,689 and 2,014 shares reported as dispositions were withheld by the company at $9.40 per share. They were used to satisfy tax withholding obligations tied to restricted stock that vested on March 31, 2026, rather than sold in the open market.

What role does Susan E. Ball hold at Cross Country Healthcare (CCRN)?

Susan E. Ball serves as General Counsel and Secretary at Cross Country Healthcare. The Form 4 filing shows equity compensation in the form of restricted common stock and related tax-withholding transactions associated with her executive compensation package.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ball Susan E

(Last) (First) (Middle)

C/O CROSS COUNTRY HEALTHCARE, INC.

5201 CONGRESS AVENUE, SUITE 160

(Street)

BOCA RATON FLORIDA 33487

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CROSS COUNTRY HEALTHCARE INC [ CCRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		33,644(1)	A	$0	245,480	D
Common Stock	03/31/2026		F		1,689(2)	D	$9.4	243,791	D
Common Stock	03/31/2026		F		2,014(2)	D	$9.4	241,777	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

2. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

	/s/ Susan E. Ball	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)